H, J., KH, K., SY, W., YH, C., HJ, K., H, K., . . . JH, M. (2026). Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA network open, 9(2), e2559471. https://doi.org/10.1001/jamanetworkopen.2025.59471
Chicago Style (17th ed.) CitationH, Ju, et al. "Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease." JAMA Network Open 9, no. 2 (2026): e2559471. https://doi.org/10.1001/jamanetworkopen.2025.59471.
MLA (9th ed.) CitationH, Ju, et al. "Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease." JAMA Network Open, vol. 9, no. 2, 2026, p. e2559471, https://doi.org/10.1001/jamanetworkopen.2025.59471.